| __timestamp | BioMarin Pharmaceutical Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 621276000 | 1256834000000 |
| Thursday, January 1, 2015 | 737887000 | 1271973000000 |
| Friday, January 1, 2016 | 907234000 | 1173296000000 |
| Sunday, January 1, 2017 | 1071860000 | 1274610000000 |
| Monday, January 1, 2018 | 1175948000 | 1437534000000 |
| Tuesday, January 1, 2019 | 1344582000 | 2201424000000 |
| Wednesday, January 1, 2020 | 1336183000 | 2203504000000 |
| Friday, January 1, 2021 | 1375760000 | 2462160000000 |
| Saturday, January 1, 2022 | 1612370000 | 2783406000000 |
| Sunday, January 1, 2023 | 1842161000 | 2832257000000 |
| Monday, January 1, 2024 | 2273680000 | 2832257000000 |
In pursuit of knowledge
The pharmaceutical industry has long been a cornerstone of global healthcare, with companies like Takeda Pharmaceutical Company Limited and BioMarin Pharmaceutical Inc. leading the charge. Over the past decade, Takeda has consistently demonstrated robust financial performance, with its gross profit peaking at approximately 2.83 trillion yen in 2023, marking a significant 125% increase from 2014. In contrast, BioMarin, while smaller in scale, has shown impressive growth, with its gross profit rising by nearly 196% over the same period, reaching 1.84 billion dollars in 2023.
This analysis highlights the dynamic nature of the pharmaceutical sector, where strategic investments and innovation drive financial success. While Takeda's growth reflects its expansive global reach, BioMarin's trajectory underscores the potential of specialized biotech firms. Notably, data for 2024 is incomplete, suggesting ongoing developments in this ever-evolving industry.
Sanofi vs Takeda Pharmaceutical Company Limited: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Sanofi vs BioMarin Pharmaceutical Inc.
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Biogen Inc.
Key Insights on Gross Profit: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Catalent, Inc.
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Exelixis, Inc.
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Pharming Group N.V.
Takeda Pharmaceutical Company Limited vs Perrigo Company plc: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Bio-Techne Corporation vs BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. and Catalent, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: BioMarin Pharmaceutical Inc. vs Corcept Therapeutics Incorporated
BioMarin Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis